Founded in 1997, with initial on-site operations beginning in November 1999, ScinoPharm® Taiwan offers a wide array of process R&D services and API manufacturing capabilities designed to satisfy customers' exact requirements and facilitate their rapid market introductions. ScinoPharm specializes in process R&D and the production of cGMP Active Pharmaceutical Ingredients (APIs).

ScinoPharm targets three market segments in the global pharmaceutical industry: Custom Synthesis for early phase pharmaceutical activities , including the supply of gram quantities for use as building blocks, drug screening, purity standards, etc. ScinoPharm can supply cGMP materials beginning at the IND stage and continuing through clinical needs as well as launch and post-launch supply requirements. Generic API manufacturing with products provided years before originator/brand patents expire. Processes are guaranteed to be non-infringing, and products are supplied at price-competitive levels. Exclusive or semi-exclusive supply arrangements can be provided. Brand company outsourcing services are available utilizing ScinoPharm's complete scale of cGMP-qualified equipment, built and operated to Western API standards. Three large and 4 smaller production suites are available.

Our Corporate Values   Unquestionable Business Ethics Commitment to Quality and Safety Equal Partnership with Customers Equal Opportunity/Diversity of Workforce Continuing Creativity and Innovation in Technology and Management

Located in the largest Science-based Industrial Park in Taiwan, ScinoPharm invested over US$200 million in the new API facilities and operating services capable of process R&D and manufacturing API's ranging from grams to metric tons.

Experience
Benefiting from in-depth international pharmaceutical and regulatory experience, our senior management team has successfully recruited a highly professional team and set up complete SOP's along with extensive technical and cultural training programs. Presently, there are over 300 full time employees to provide infrastructure and technical and operating personnel to support on-going collaborations in developing and manufacturing numerous APIs.

R&D Strength
There are currently 80 R&D scientists at the Taiwan site and an additional 25 process chemists at our Process R&D Center in Kunshan, Jiangshu, near Shanghai, China.

Intellectual Property
At ScinoPharm Taiwan, we employ advanced patent search software and subscription services to ensure that our developmental chemistry does not infringe on any existing or pending patents. We provide legal assurances from U.S. patent attorneys that our chemical processes avoid any infringement problems.